KRAS and neoplasm: Previously, we showed that Stk11 (Lkb1) deletion concomitant with induction of oncogenic KRAS drove acquisition of aggressive tumour characteristics, including SCC transition, not observed in KRAS tumours when Lkb1 is intact26.